Nov. 2, 2022
Are drug companies the villain?
New research from the University of Missouri calls for more relevant data to support claims of “evergreening” or manipulation by brand drug companies in pharmaceutical industry.
Oct. 25, 2022
Interdimensional collaboration
Exploring the areas of virtual reality, augmented reality, mixed reality and artificial intelligence, Mizzou scholars are working across disciplines to enter the metaverse.
Oct. 24, 2022
Team develops new method to determine lifespan of lithium-ion batteries
A new study from the College of Engineering looks at historical data, theoretical assumptions and real-world factors to see how long your battery will last.
Oct. 21, 2022
$8 million grant will expand National Swine Resource and Research Center at MU
NIH grant will support research with genetically modified pigs to study human diseases.
Oct. 19, 2022
Reversing drug resistance in lung cancer
University of Missouri researchers were awarded a $2.35 million grant from the National Cancer Institute to help overcome drug resistance in non-small cell lung cancer.
Oct. 19, 2022
Growth and discovery: NextGen marks one year
NextGen researchers have been awarded $97 million in grants in first year.
Oct. 18, 2022
A smoky solution — for plants
After MU researchers started examining the impact of smoke on plant growth after a wildfire, their surprising discovery could one day lead to new farming practices.
Oct. 17, 2022
MU hosts dedication, ribbon cutting of new $30 million School of Nursing building
Oct. 13, 2022
Years in the making
Recent successful partial heart transplant in infant linked to MU researcher Randall Prather’s decades long work with genetically modified pigs.
Oct. 12, 2022
At the forefront of nuclear medicine
For decades, MU has been a leader in developing lifesaving cancer treatments and is now set to play an integral role in an ongoing radiopharmaceutical renaissance.